Results 251 to 260 of about 1,790,741 (301)

"S-Tau-Lled" Lysosomes Disrupt Autophagic Processes in Neurodegeneration. [PDF]

Traffic
Bécot A, Kabani M.
europepmc   +1 more source

Pricing Dynamics in the US Hemp Market: A Vertical Price Transmission Analysis of the Hemp Value Chain

Agribusiness, EarlyView.
ABSTRACT The US hemp market is a new and nascent industry that has been devoid of research for about half a century. This study examined the effects of exogenous shock on price at each phase of the value chain—Farm (hemp biomass), and its impact on prices at other phases of the value chain—Intermediary Processor (crude cannabidiol hemp) and Final ...
Solomon Odiase, Tyler Mark, Patalee Buddhika Appuhamilage   +2 more
wiley   +1 more source

A proteomic analysis of the PHF-forming tau fragment (tau297-391) following uptake into differentiated human neuronal SHSY5Y cells. [PDF]

Biosci Rep
Copsey A, Oakley SS, Maina MB, Parker R, Marshall KE, Harrington CR, Storey JMD, Wischik CM, Serpell LC.   +8 more
europepmc   +1 more source

Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy? [PDF]

Mol Neurodegener Adv
Buck SA, Madhavan SS, Sanders LH.
europepmc   +1 more source

When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases. [PDF]

Mol Neurobiol
Hunt JN, Kortagere S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Functions and malfunctions of the tau proteins

Cellular and Molecular Life Sciences, 2002
The tau proteins belong to the family of microtubule-associated proteins. They are mainly expressed in neurons where they play major regulatory roles in the organization and integrity of the cytoskeleton network. Neurofibrillary changes of abnormally hyperphosphorylated tau are a key lesion in Alzheimer's disease and a number of other tauopathies ...
Roland Brandt
exaly   +3 more sources

Tau protein and tau aggregation inhibitors

Neuropharmacology, 2010
Alzheimer disease is characterized by pathological aggregation of two proteins, tau and Abeta-amyloid, both of which are considered to be toxic to neurons. In this review we summarize recent advances on small molecule inhibitors of protein aggregation with emphasis on tau, with activities mediated by the direct interference of self-assembly.
Bulic, B., Pickhardt, M., Mandelkow, E., Mandelkow, E.   +3 more
openaire   +3 more sources

The discovery of tau protein

Cytoskeleton, 2023
AbstractIn January of this year I received an unexpected request from George Bloom to contribute an historical perspective on “the discovery of tau protein,” an event that occurred roughly 50 years ago. My first thought was that it could not have been that long ago, as the memories of what was my first independent scientific discovery are still fresh ...
openaire   +2 more sources

Differential distribution of tau proteins in developing cat cerebellum

Brain Research Bulletin, 1994
The differential distribution and phosphorylation of tau proteins in cat cerebellum was studied with two well characterized antibodies, TAU-1 and TAU-2.
B M Riederer, Lester I Binder, Beat M Riederer   +2 more
exaly   +2 more sources

Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration

Journal of Alzheimer's Disease, 2019
Tauopathies are a specific type of slow and progressive neurodegeneration, which involves intracellular deposition of fibrillar material composed of abnormal hyperphosphorylation of the microtubule associated protein (MAP) tau. Despite many years of intensive research, our understanding of the molecular events that lead to neurodegeneration is far from
Yuanting, Ding, Lijuan, Lei, Chencen, Lai, Zhi, Tang   +3 more
openaire   +2 more sources